Intracellular localization of beta-catenin expression plays a possible prognostic role on the outcome of hepatoblastoma patients.

Although the numbers are limited in our series, the intracellular localization of BC expression has been found to be a promising determining factor for hepatoblastoma prognosis. With larger patient series, more reliable results can be achieved.